A Survival Analysis of Patients with Recurrent Epithelial Ovarian Cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia

CONCLUSIONS: Overall, despite new therapeutic approaches, ovarian cancer continues to be one of the deadly malignant diseases affecting women, especially in developing countries with a lack of resources, where chemotherapy remains the primary available systemic treatment for the majority of patients. Low survival rates demonstrate the urgent need for more research focused on this group of patients with poor outcomes.PMID:38534933 | PMC:PMC10968888 | DOI:10.3390/curroncol31030100

Source: Current Oncology - March 27, 2024 Category: Cancer & Oncology Authors: Lilit Harutyunyan Evelina Manvelyan Nune Karapetyan Samvel Bardakhchyan Aram Jilavyan Gevorg Tamamyan Armen Avagyan Liana Safaryan Davit Zohrabyan Narine Movsisyan Anna Avinyan Arevik Galoyan Mariam Sargsyan Martin Harutyunyan Hasmik Nersoyan Arevik Stepa Source Type: research